| 000 -LEADER |
|---|
| fixed length control field |
01557cam a2200421 a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
16418623 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
Nust |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20170307111329.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
100816s2010 enka b 001 0 eng c |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2010487075 |
| 015 ## - NATIONAL BIBLIOGRAPHY NUMBER |
|---|
| National bibliography number |
GBB000104 |
| Source |
bnb |
| 016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER |
|---|
| Record control number |
101521874 |
| Source |
DNLM |
| 016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER |
|---|
| Record control number |
015452272 |
| Source |
Uk |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780853697220 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
978-0-85369-722-0 |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)ocn488979418 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
NLM |
| Transcribing agency |
NLM |
| Modifying agency |
EQO |
| -- |
UKM |
| -- |
CUD |
| -- |
YDXCP |
| -- |
BTCTA |
| -- |
BAKER |
| -- |
VRC |
| -- |
DLC |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
pcc |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RM301.4 |
| Item number |
.M65 2010 |
| 060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
2010 A-013 |
| 060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
QV 38 |
| Item number |
M7185 2010 |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.1/9 |
| Edition number |
23 |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Molecular biopharmaceutics : |
| Remainder of title |
aspects of drug characterisation, drug delivery, and dosage form evaluation / |
| Statement of responsibility, etc. |
edited by Bente Steffansen, Birger Brodin, Carsten Uhd Nielsen. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
London ; |
| -- |
Grayslake, IL : |
| Name of publisher, distributor, etc. |
Pharmaceutical Press, |
| Date of publication, distribution, etc. |
2010. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xviii, 371 p. : |
| Other physical details |
ill. ; |
| Dimensions |
25 cm. |
| 490 0# - SERIES STATEMENT |
|---|
| Series statement |
ULLA pharmacy series |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references and index. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Biopharmaceutics. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmaceutical chemistry. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Drug development. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Biopharmaceutics. |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Chemistry, Pharmaceutical. |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Drug Discovery. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Steffansen, Bente. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Brodin, Birger. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Nielsen, Carsten Uhd. |
| 906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) |
|---|
| a |
7 |
| b |
cbc |
| c |
pccadap |
| d |
2 |
| e |
ncip |
| f |
20 |
| g |
y-gencatlg |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Koha item type |
Book |
